Sinco Pharmaceuticals Holdings Limited operates as a pharmaceuticals group that primarily focuses on the development, manufacturing, and marketing of pharmaceutical and aesthetic medicine products. The company operates as a subsidiary of Risun Investment Limited.
Business Segments
The company operates three distinct business segments: The Sale of Imported Pharmaceutical Products, Research and Manufacturing of Aesthetic Medicine, and Medical Beauty Services.
Sale of Imported Pharmaceutical Pro...
Sinco Pharmaceuticals Holdings Limited operates as a pharmaceuticals group that primarily focuses on the development, manufacturing, and marketing of pharmaceutical and aesthetic medicine products. The company operates as a subsidiary of Risun Investment Limited.
Business Segments
The company operates three distinct business segments: The Sale of Imported Pharmaceutical Products, Research and Manufacturing of Aesthetic Medicine, and Medical Beauty Services.
Sale of Imported Pharmaceutical Products
This segment involves the import and distribution of various pharmaceutical products. It mainly focuses on human albumin solutions and antibiotics, with significant sales generated from these products.
Research and Manufacturing of Aesthetic Medicine
This segment innovates in the field of aesthetic medicine. A noteworthy aspect of this section is the research and development of advanced products, including polycaprolactone microsphere facial fillers that are intended for injectable use.
Medical Beauty Services
This segment focuses on offering a range of services that promote aesthetic enhancements, this segment comprises medical beauty services provided through entities like Deyang Demei Medical Beauty Hospital Limited Company. The inclusion of such a service-oriented segment reflects the company’s understanding of market.
Business Strategy
The company's strategy emphasizes innovation and market responsiveness. Driven by a commitment to delivering high-quality, innovative pharmaceutical and aesthetic medicine products, the company focuses on its strategy execution.
Geographical Markets Served
The company primarily operates within Mainland China, where it serves a broad customer base for all its pharmaceutical and aesthetic medicine needs.
Recent Acquisitions
In recent periods, Sinco Pharmaceuticals engaged in a pivotal acquisition of Deyang Demei Medical Beauty Hospital Limited Company.
Customers
The company primarily serves a diverse range of customers, including healthcare institutions, clinics, and individual consumers seeking pharmaceutical and aesthetic solutions.
Modes of Sales and Marketing
The company utilizes various sales and marketing strategies to reach its targeted consumer segments effectively. This often includes direct engagement with healthcare providers, online marketing, promotional events, and strategic partnerships to promote its pharmaceutical and aesthetic offerings.
Distribution Channels
The distribution channels are primarily focused on ensuring that products are readily available in hospitals, clinics, and other retail environments where customers seek healthcare solutions. By employing a combination of these methods.
History
Sinco Pharmaceuticals Holdings Limited was founded in 2011. The company was incorporated in 2015.